Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_assertion type Assertion NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_head.
- NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_assertion wasGeneratedBy ECO_0000203 NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_provenance.
- NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_assertion wasDerivedFrom befree-20150227 NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_provenance.
- NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_assertion SIO_000772 21224376 NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_provenance.
- NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_assertion evidence source_evidence_literature NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_provenance.
- NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_assertion description "[Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353402.RA9f8PvhN9TemdEAb3agZma67-okworKz3njDnWPCCEIQ130_provenance.